KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Merck (MRK) Accumulated Depreciation & Amortization (2016 - 2025)

Merck (MRK) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $21.9 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 14.4% to $21.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 billion through Dec 2025, up 14.4% year-over-year, with the annual reading at $21.9 billion for FY2025, 14.4% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $21.9 billion at Merck, up from $19.2 billion in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $21.9 billion in Q4 2025, with the low at $158.0 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $8.6 billion, with a median of $358.0 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization plummeted 54.71% in 2021, then soared 9936.26% in 2023.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $158.0 million in 2021, then grew by 15.19% to $182.0 million in 2022, then skyrocketed by 9936.26% to $18.3 billion in 2023, then rose by 4.87% to $19.2 billion in 2024, then increased by 14.4% to $21.9 billion in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $21.9 billion, $19.2 billion, and $18.3 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.